Filter
788
Filtered Results: 788
Text search:
D.
Fung
Featured
Recommendations
98
New Publications
173
Language
Document type
No document type
382
Guidelines
159
Studies & Reports
142
Manuals
45
Training Material
28
Strategic & Response Plan
11
Fact sheets
9
Situation Updates
5
Infographics
4
Brochures
2
Videos
1
Countries / Regions
Indonesia
74
India
59
Global
32
Germany
20
Kenya
19
South Africa
19
Nepal
15
Latin America and the Carribbean
14
Tanzania
11
Brazil
11
Ghana
10
Africa
10
Philippines
9
Mozambique
9
Congo, Democratic Republic of
9
Uganda
9
Ethiopia
9
Angola
9
Nigeria
7
Malawi
7
Russia
7
Western and Central Europe
6
Zambia
6
Myanmar / Burma
5
Syria
4
South–East Asia Region
4
Bangladesh
4
Eswatini/ Swaziland
4
Colombia
3
Ukraine
3
Sierra Leone
3
Rwanda
3
Senegal
3
Burkina Faso
3
Guinea-Bissau
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Botswana
3
Thailand
2
El Salvador
2
China
2
Zimbabwe
2
USA
2
Haiti
2
Cambodia
2
North America
2
Spain
2
Argentina
2
Papua New Guinea
2
Namibia
2
Yemen
2
South Sudan
2
Liberia
2
Switzerland
1
Lesotho
1
Cameroon
1
Laos
1
Mongolia
1
Qatar
1
Italy
1
West and Central Africa
1
Paraguay
1
Gabon
1
France
1
Mauritius
1
East and Southern Africa
1
Bolivia
1
Vietnam
1
Eastern Europe
1
Sri Lanka
1
Sudan
1
Romania
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
327
Clinical Guidelines
84
Public Health
38
Key Resources
29
Pharmacy & Technologies
27
Capacity Building
19
Women & Child Health
18
Toolboxes
AMR
75
COVID-19
64
Planetary Health
41
Pharmacy
34
Mental Health
32
HIV
30
NTDs
29
TB
28
NCDs
21
Refugee
20
Caregiver
15
Global Health Education
12
Disability
11
Rapid Response
10
Health Financing Toolbox
10
Specific Hazards
8
Natural Hazards
6
Conflict
6
Ebola
5
Polio
3
Cholera
1
Social Ethics
1
Health Financing
1
Zika
1
Molecular methods for antimicrobial resistance (AMR)diagnostics to enhance the Global Antimicrobial Resistance Surveillance System
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In addition, there is compelling evidence that antimicro...
The Ghanaian Cabinet approved the antimicrobial resistance (AMR)Policy and Implementation plan(hereafter referred to as the national action plan or NAP)in December 2017, whilst the country case study was in progress. This has set in motion the implementation phase for Ghana, which is a long awaited...
The international community sits at the tipping pointof a post-‐antibiotic era, where common bacterial infections are no longer treatable with the antibiotic armamentarium that exists. In South Africa, t...
23 December 2020 This document summarizes WHO recommendations for the rational use of personal protective equipment (PPE) in health care settings and temporary strategies during acute supply shortages. This document also contains 2 Annex sections describing updated PPE use recommendations for health...
Infection Prevention and Control Programmes
January 2020
Tercera versión, 1 de febrero del 2022. Estas orientaciones tienen por objetivo contribuir a que los sistemas de salud prioricen los medicamentos esenciales que deben estar disponibles y ser asequibles para manejar los pacientes en las unidades de cuidado intensivos durante las emergencias de salud...
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for us...
O objetivo deste documento é fornecer orientações provisórias de biossegurança laboratorial para testes com amostras clínicas de pacientes que atendam à definição de casos do novo patógeno identificado em Wuhan, China, ou seja, a doença do coronavírus 2019 (COVID-19). A OMS revisará ess...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri...
The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is ...
2nd edition
stas Pranchas para o diagnóstico de parasitos intestinais destinam-se a servir tanto como orientação para profissionais de laboratório e de campo em países endêmicos quanto como material de ensino para estudantes e estagiários. Contêm orientações sobre a escolha da preparação para os d...
Updated July 3, 2020
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent...
N95 or equivalent respirators are single-use personal protective equipment (PPE) designed for use by health workers that provide direct care to patients with diseases transmitted by aerosols or during aerosol generating procedures (AGP) for patients with acute respiratory disease, as is the case of ...
Centro de tratamiento de infecciones respiratorias agudas graves: manual práctico para instalar y gestionar un centro de tratamiento de las infecciones respiratorias agudas graves y una zona para el tamizaje de estas en los establecimientos de asistencia médica
